Company Filing History:
Years Active: 2019
Title: Innovations of Zhuzi He in Antibody Development
Introduction
Zhuzi He is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic use. His work focuses on enhancing the efficacy of treatments for HER2 positive tumors.
Latest Patents
Zhuzi He holds a patent for a "Mutated antibody of fully humanized HER2 antibody, and encoding gene and use thereof." This invention provides a mutated antibody of the fully humanized HER2 antibody GB235-019. The amino acid sequences of the heavy chain variable region and the light chain variable region of the mutated antibody are specified as SEQ ID NO: 10, SEQ ID NO: 2; SEQ ID NO: 11, SEQ ID NO: 2; or SEQ ID NO: 12, SEQ ID NO: 2. The mutated antibody is designed to specifically bind to the human HER2 antigen, similar to the GB235-019 antibody. It can also be used in combination with additional HER2 positive tumor therapeutic agents for treating HER2 positive tumors, weakly positive tumors, or negative tumors.
Career Highlights
Zhuzi He is associated with Genor Biopharma Co., Ltd., where he continues to innovate in the field of antibody research. His work has the potential to significantly impact cancer treatment and improve patient outcomes.
Collaborations
Zhuzi He collaborates with notable colleagues, including Qing Zhou and Mengjun Shu. Their combined expertise contributes to the advancement of biopharmaceutical developments.
Conclusion
Zhuzi He's innovative work in antibody development showcases his commitment to improving cancer therapies. His contributions are vital in the ongoing fight against HER2 positive tumors, and his patent reflects the potential for significant advancements in medical treatments.